DOXORUBICIN-LANS®

DOXORUBICIN
DOXORUBICIN-LANS®

Available Presentations:

  • LYOPHILIZATE FOR INTRAVASCULAR SOLUTION, VIALS, 10 mg and 50 mg
  • INTRAVASCULAR AND INTRAVESICAL SOLUTION, 2 mg/mL, VIALS, 10 mg/5 mL; 25 mg/12.5 mL; 50 mg/25 mL; 75 mg/37.5 mL and 150 mg/75 mL
INN: doxorubicin
Presentation:
Lyophilizate for intravascular solution, vials, 10 mg and 50 mg
Intravascular and intravesical solution, 2 mg/mL, vials, 10 mg/5 mL; 25 mg/12.5 mL; 50 mg/25 mL; 75 mg/37.5 mL and 150 mg/75 mL
ATC Group: L01DB01
Product for chemotherapy of malignant neoplasms, antitumoral antibiotic
Scope of Application: treatment of malignant neoplasms of different localizations
Status of Administration: prescription only
VED Status: listed in VED List
Marketing Authorization: LS 002609 and PN 000005/01
Shelf Life: lyophilizate: 3 years, solution: 2 years
Conditions of Storage: store at or below 8°C

THE INFORMATION ON THIS PAGE IS NOT AN ADVERTISEMENT AND IS INTENDED TO INFORM ON THE PRODUCTS MANUFACTURED BY THE COMPANY.

THE MEDICINAL PRODUCTS HAVE CONTRAINDICATIONS, CONTACT YOUR DOCTOR.